A timely primer on the new reality of antisense and RNA inhibition
for treating a broad range of diseases. The authors show how
antisense oligonucleotides are being designed and studied in
relation to hypertension, various cancers, inflammatory bowel
disease, brain disorders, the blood-brain barrier, and drug
delivery. Highlights include RNA-based therapies for many diseases,
up-to-date methods and applications, and insight into the enormous
potential to provide a new generation of drugs.
General
Imprint: |
HumanaPress
|
Country of origin: |
United States |
Series: |
Methods in Molecular Medicine, 106 |
Release date: |
September 2004 |
First published: |
2005 |
Editors: |
M.Ian Phillips
|
Dimensions: |
229 x 152 x 29mm (L x W x T) |
Format: |
Hardcover
|
Pages: |
344 |
Edition: |
2nd ed. 2005 |
ISBN-13: |
978-1-58829-205-6 |
Categories: |
Books >
Medicine >
Clinical & internal medicine >
General
Promotions
|
LSN: |
1-58829-205-3 |
Barcode: |
9781588292056 |
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!